---
title: "LKPC's application for the issuance of stocks to specific objects has been approved for registration by the China Securities Regulatory Commission"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259311422.md"
description: "According to the Zhitong Finance APP, LKPC announced that the company recently received the \"Approval on Shandong LKPC Co., Ltd. to Issue Stocks to Specific Objects\" issued by the China Securities Regulatory Commission (referred to as \"CSRC\") (CSRC Permit [2025] No. 2158), approving the company's application for stock issuance registration to specific objects"
datetime: "2025-09-29T10:34:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259311422.md)
  - [en](https://longbridge.com/en/news/259311422.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259311422.md)
generator: "portal-rs"
---

# LKPC's application for the issuance of stocks to specific objects has been approved for registration by the China Securities Regulatory Commission

According to the Zhitong Finance APP, LKPC (600789.SH) announced that the company recently received the "Approval on Shandong LKPC Co., Ltd. to Issue Stocks to Specific Objects" issued by the China Securities Regulatory Commission (CSRC) (Zheng Jian Xu Ke \[2025\] No. 2158), approving the company's application for stock issuance registration to specific objects

### Related Stocks

- [600789.CN](https://longbridge.com/en/quote/600789.CN.md)

## Related News & Research

- [Peru to join US anti-drug coalition after Rubio visit](https://longbridge.com/en/news/298628026.md)
- [CityWalk e-Bike wins approval for planned 25,000-vehicle rollout in Chengdu, Foshan](https://longbridge.com/en/news/298458546.md)
- [Nanoscope Therapeutics to Participate in the 28th Annual H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/298721995.md)
- [Guidance for the 2026/27 financial year](https://longbridge.com/en/news/298632463.md)
- [Omnia Technologies acquires BRAM-COR, Siempharma, C.Matic, Formartis](https://longbridge.com/en/news/298590913.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**